Möchten Sie immer auf dem neuesten Stand bleiben?

REGULATED INFORMATION GHENT, Belgium, April 21, 2015 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in conformity with Title II of the Law of 2 May 2007 and the...

REGULATED INFORMATION GHENT, Belgium, April 15, 2015 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding...

GHENT, Belgium, April 7, 2015 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX; OTC ABYLY] today announced the publication of its 2014 Annual Report which can now be downloaded from the Company's...

            Phase IIb study to evaluate ALX-0061 monotherapy in adult patients with active rheumatoid arthritis (RA) who are intolerant to...

GHENT, Belgium, March 26, 2015 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced an extension of its initial two-year research collaboration with Merck & Co., Inc.,...

GHENT/ZWIJNAARDE, Belgium, March 17, 2015 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced that it has administered the first dose in the Phase IIb study to evaluate...

Ghent, Belgium, March 16, 2015 (GLOBE NEWSWIRE) -- Ablynx (Euronext Brussels: ABLX) (OTC:ABYLY) today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14...

GHENT, Belgium, March 16, 2015 (GLOBE NEWSWIRE) -- REGULATED INFORMATION Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007...

GHENT, Belgium, March 3, 2015 (GLOBE NEWSWIRE) -- REGULATED INFORMATION Ablynx [Euronext Brussels: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding...

GHENT, Belgium, Feb. 26, 2015 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX] today announced its consolidated results for 2014, which have been prepared in accordance with IFRS as adopted by the...